Wayback Machine
Nov DEC Jan
Previous capture 21 Next capture
2014 2015 2016
1 captures
21 Dec 15 - 21 Dec 15
sparklines
Close Help
Bisoprolol Improves RVEF and Heart Rate in PAH

Summary

Treatment of idiopathic pulmonary arterial hypertension (PAH) with the β-blocker bisoprolol resulted in decreased heart rate, increased right ventricular ejection fraction (RVEF), and improved quality of life. This article presents data from the Beta-Blocker Therapy in Idiopathic Pulmonary Arterial Hypertension trial [NCT01246037; Van Campen JSJA et al. Am J Respir Crit Care 2014].

  • Thromboembolic Disease
  • Pulmonary Clinical Trials
  • Hypertensive Disease
  • Pulmonary & Critical Care
  • Thromboembolic Disease
  • Pulmonary Clinical Trials
  • Hypertensive Disease
View Full Text